Zydus receives EIR for the Pre-Approval Inspection at the manufacturing facility in Moraiya, Ahmedabad

The Zydus Group has received the Establishment Inspection Report (EIR) from the USFDA for the inspection conducted at the manufacturing facility of Zydus Lifesciences Limited located at Moraiya, Ahmedabad from 23rd to 27th January, 2023. The inspection was a PAI for Transdermal Patch products. The Audit had ended with NIL observations.

Shares of Cadila Healthcare Limited was last trading in BSE at Rs. 524.70 as compared to the previous close of Rs. 525.20. The total number of shares traded during the day was 27091 in over 1283 trades.

The stock hit an intraday high of Rs. 530.70 and intraday low of 515.05. The net turnover during the day was Rs. 14293064.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 USFDA IER Moraiya Ahmedabad ManufacturingFacility